ACE and chronic kidney disease: This finding is consistent with a large cohort study involving 6714 participants that examined the relationship between ACE I/D polymorphism and cardiovascular morbidity and mortality, wherein no direct association was determined between polymorphisms and myocardial infarction, significant morbidity, or risk factor for death in CKD patients [46].